Oncoinvent closes $ 25 Million Private Placement
08 February 2017
08 February 2017
Total investments received (USD): 58.79m
Round value (USD): 25m
Company: Oncoinvent
Industry:
Biotech
Health services
Related deals
Vaccibody raised NOk 220M to initiate its clinical development of targeted personalized neoantigen-based cancer vaccines for the 2017-20 period.
Investments
15 December 2016
The Future Group pulls in $20 mln Series C
Investments
03 November 2016
Bonesupport Raises $37m in Financing
Investments
27 October 2016
Completion of $22M of additional funding for growing Questback further
Investments
19 October 2016
Belgium
Netherlands
Austria
Germany
Switzerland
Estonia
Finland
Iceland
Latvia
Lithuania
France
Ireland
Italy
Portugal
Spain
United Kingdom